High serum levels of interleukin-6 in patients with advanced or metastatic colorectal cancer: the effect on the outcome and the response to chemotherapy plus bevacizumab
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High serum levels of interleukin-6 in patients with advanced or metastatic colorectal cancer: the effect on the outcome and the response to chemotherapy plus bevacizumab
Authors
Keywords
Colorectal cancer, Bevacizumab, Interleukin-6 (IL-6), Chemo-resistance
Journal
SURGERY TODAY
Volume 47, Issue 4, Pages 483-489
Publisher
Springer Nature
Online
2016-08-22
DOI
10.1007/s00595-016-1404-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- B7-H4 facilitates proliferation of esophageal squamous cell carcinoma cells through promoting interleukin-6/signal transducer and activator of transcription 3 pathway activation
- (2016) Xinran Chen et al. CANCER SCIENCE
- Preoperative Serum Interleukin-6 Is a Potential Prognostic Factor for Colorectal Cancer, including Stage II Patients
- (2016) Kazuyoshi Shiga et al. Gastroenterology Research and Practice
- Upregulated interleukin-6 expression contributes to erlotinib resistance in head and neck squamous cell carcinoma
- (2015) Aditya Stanam et al. Molecular Oncology
- Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth
- (2015) Kazuyoshi Shiga et al. Cancers
- Aqueous Interleukin-6 Levels Are Superior to Vascular Endothelial Growth Factor in Predicting Therapeutic Response to Bevacizumab in Age-Related Macular Degeneration
- (2014) Kakarla V. Chalam et al. Journal of Ophthalmology
- Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy
- (2013) J M Jürgensmeier et al. BRITISH JOURNAL OF CANCER
- Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour–stroma interaction
- (2013) T Nagasaki et al. BRITISH JOURNAL OF CANCER
- Interleukin-6: An angiogenic target in solid tumours
- (2013) Kathryn Middleton et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Proangiogenic tumor proteins as potential predictive or prognostic biomarkers for bevacizumab therapy in metastatic colorectal cancer
- (2013) Maressa A. Bruhn et al. INTERNATIONAL JOURNAL OF CANCER
- Predictive Impact of Circulating Vascular Endothelial Growth Factor in Four Phase III Trials Evaluating Bevacizumab
- (2012) P. S. Hegde et al. CLINICAL CANCER RESEARCH
- Monoclonal antibodies in lung cancer
- (2012) Yujiong Wang et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Changes in Circulating Pro-Angiogenic Cytokines, other than VEGF, before Progression to Sunitinib Therapy in Advanced Renal Cell Carcinoma Patients
- (2012) Camillo Porta et al. ONCOLOGY
- Predictive and Prognostic Biomarkers for Targeted Therapy in Metastatic Colorectal Cancer
- (2011) Uzma Asghar et al. Clinical Colorectal Cancer
- Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
- (2011) Atsushi Ohtsu et al. JOURNAL OF CLINICAL ONCOLOGY
- Signaling Pathways Governing Tumor Angiogenesis
- (2011) Toshiharu Sakurai et al. ONCOLOGY
- Phase II Trial of Bevacizumab and Everolimus in Patients With Advanced Renal Cell Carcinoma
- (2010) John D. Hainsworth et al. JOURNAL OF CLINICAL ONCOLOGY
- Combined targeting of interleukin-6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness
- (2009) Ahlame Saidi et al. INTERNATIONAL JOURNAL OF CANCER
- Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study
- (2009) Christopher G. Willett et al. JOURNAL OF CLINICAL ONCOLOGY
- Antitumor effect of the angiogenesis inhibitor bevacizumab is dependent on susceptibility of tumors to hypoxia-induced apoptosis
- (2007) Muthu Selvakumaran et al. BIOCHEMICAL PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started